Bihain

Biography

  Dr. Bihain created GENCLIS in 2004. After receiving his Doctorate in Medicine from the Free University of Brussels in 1984, Bernard began a surgery internship. In 1988, he left his internship to devote himself exclusively to research as a Postdoctoral Fellow at Columbia University, NY, USA. Thereafter, Dr. Bihain took a position in 1990 as Assistant Professor of Physiology at the University of Louisiana, New Orleans, USA. He was awarded the position of Research Director at INSERM in 1992 and became Professor and Chairman of the Department of Biochemistry, University of Rennes, where INSERM Unit 391 was created in 1994. He then undertook the direction of the Department of Functional Genomics of Genset, a listed genomics company that was acquired by Merck-Serono. Dr. Bihain later became CSO of Valigen, but left this position to focus on the creation of GENCLIS. He has actively contributed to the emergence of genomic technologies. His pragmatism, stemming from his experience as a surgeon, powers the translational activities of GENCLIS. Dr. Bihain has authored over 50 publications in peer-reviewed journals, and his studies are cited in more than 5000 scientific articles.

Research Interest

Bioinformatics and system biology